Freedom of information, when it suits. - Suppr | 超能文献

Freedom of information, when it suits.

出版信息

Lancet. 1998 Aug 29;352(9129):665.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Freedom of information, when it suits.

Lancet. 1998 Aug 29;352(9129):665.

2

Intellectual property, drug licensing, freedom of information, and public health.知识产权、药品许可、信息自由与公共卫生。

Lancet. 1998 Aug 29;352(9129):726-9. doi: 10.1016/S0140-6736(98)07600-4.

3

Medicines regulation and the pharmaceutical industry.药品监管与制药行业。

BMJ. 2005 Oct 8;331(7520):834-6. doi: 10.1136/bmj.331.7520.834.

4

European Medicines Agency pledges to publish clinical reports.欧洲药品管理局承诺发布临床报告。

BMJ. 2014 Oct 7;349:g6086. doi: 10.1136/bmj.g6086.

5

Japan works to shorten "drug lag," boost trials of new drugs.日本致力于缩短“药品滞后”现象，推动新药试验。

J Natl Cancer Inst. 2010 Feb 3;102(3):148-51. doi: 10.1093/jnci/djq017. Epub 2010 Jan 27.

6

UK government tightens rules for drug regulators.英国政府收紧药品监管机构的规定。

BMJ. 2004 Nov 20;329(7476):1203. doi: 10.1136/bmj.329.7476.1203-b.

7

Tort claims and federal regulation of medical devices vs pharmaceuticals.侵权索赔与医疗器械和药品的联邦监管

JAMA. 2009 Sep 16;302(11):1169; author reply 1169-70. doi: 10.1001/jama.2009.1333.

8

Patent protection for medical technologies: why some and not others?

Lancet. 1998 Feb 14;351(9101):518-9. doi: 10.1016/S0140-6736(97)02432-X.

9

[European drug policy: welcomed modernization but shortage of political proposals concerning industry and research].[欧洲毒品政策：欢迎现代化，但缺乏有关产业和研究的政治提案]

Lakartidningen. 2003 Oct 30;100(44):3541-2.

10

EU court gets tough on patent extensions for combo products.欧盟法院对组合产品的专利延期采取强硬态度。

Nat Med. 2012 Jan 6;18(1):4. doi: 10.1038/nm0112-4b.

引用本文的文献

1

Manufacturer's drug interaction and postmarketing adverse event data: what are appropriate uses?制造商的药物相互作用和上市后不良事件数据：有哪些适当的用途？

Drug Saf. 2001;24(9):637-43. doi: 10.2165/00002018-200124090-00001.